Single-Digit Restenosis Rates Justify Coated Stent Price Premium - Guidant
This article was originally published in The Gray Sheet
Executive Summary
Guidant expects its paclitaxel-coated stent agreement with Cook, Inc. to yield at least a $1,000 price premium over conventional coronary stents in the U.S.